secwatch / observer
8-K filed April 1, 2024, 7:59 PM ET ticker BRGX CIK 0001593184
M&A confidence high sentiment neutral materiality 0.90

BIOREGENX, INC. (BRGX): M&A transaction — BioRegenx completes reverse merger with Findit; new board, name change effective March 8, 2024

BIOREGENX, INC.

item 2.01item 3.02item 5.01item 5.02item 5.03item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Sherri Adams

director
BRGX · BIOREGENX, INC.
Effective
2024-03-08
Filed
April 1, 2024, 7:59 PM ET
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides, Robert Doran, Sherri Adams, Gary Hennerberg, Suzanne Bird, Jody Walker, Gary Kiss
Appointed

Gary Hennerberg

Secretary
BRGX · BIOREGENX, INC.
Effective
2024-03-08
Filed
April 1, 2024, 7:59 PM ET
the following officers were appointed: William Resides – Chief Executive Officer, Interim Financial Officer Robert Doran – Executive Vice President Sherri Adams – Chief Operating Officer Gary Hennerberg – Secretary
Appointed

Jody Walker

director
BRGX · BIOREGENX, INC.
Effective
2024-03-08
Filed
April 1, 2024, 7:59 PM ET
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides, Robert Doran, Sherri Adams, Gary Hennerberg, Suzanne Bird, Jody Walker, Gary Kiss
Appointed

Gary Hennerberg

director
BRGX · BIOREGENX, INC.
Effective
2024-03-08
Filed
April 1, 2024, 7:59 PM ET
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides, Robert Doran, Sherri Adams, Gary Hennerberg, Suzanne Bird, Jody Walker, Gary Kiss
Appointed

Robert Doran

director
BRGX · BIOREGENX, INC.
Effective
2024-03-08
Filed
April 1, 2024, 7:59 PM ET
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides, Robert Doran, Sherri Adams, Gary Hennerberg, Suzanne Bird, Jody Walker, Gary Kiss
Departed

Raymond Firth

director
BRGX · BIOREGENX, INC.
Effective
2024-03-08
Filed
April 1, 2024, 7:59 PM ET
Effective March 8, 2024, Raymond Firth resigned as a director of the Registrant
Appointed

William Resides

director
BRGX · BIOREGENX, INC.
Effective
2024-03-08
Filed
April 1, 2024, 7:59 PM ET
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides, Robert Doran, Sherri Adams, Gary Hennerberg, Suzanne Bird, Jody Walker, Gary Kiss
Appointed

Sherri Adams

Chief Operating Officer
BRGX · BIOREGENX, INC.
Effective
2024-03-08
Filed
April 1, 2024, 7:59 PM ET
the following officers were appointed: William Resides – Chief Executive Officer, Interim Financial Officer Robert Doran – Executive Vice President Sherri Adams – Chief Operating Officer Gary Hennerberg – Secretary
Appointed

Robert Doran

Executive Vice President
BRGX · BIOREGENX, INC.
Effective
2024-03-08
Filed
April 1, 2024, 7:59 PM ET
the following officers were appointed: William Resides – Chief Executive Officer, Interim Financial Officer Robert Doran – Executive Vice President Sherri Adams – Chief Operating Officer Gary Hennerberg – Secretary
Appointed

Suzanne Bird

director
BRGX · BIOREGENX, INC.
Effective
2024-03-08
Filed
April 1, 2024, 7:59 PM ET
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides, Robert Doran, Sherri Adams, Gary Hennerberg, Suzanne Bird, Jody Walker, Gary Kiss
Departed

Thomas Powers

Other Named Officer
BRGX · BIOREGENX, INC.
Effective
2024-03-08
Filed
April 1, 2024, 7:59 PM ET
Effective March 8, 2024, Raymond Firth and Thomas Powers resigned as officers of the Registrant
Appointed

Gary Kiss

director
BRGX · BIOREGENX, INC.
Effective
2024-03-08
Filed
April 1, 2024, 7:59 PM ET
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides, Robert Doran, Sherri Adams, Gary Hennerberg, Suzanne Bird, Jody Walker, Gary Kiss
Departed

Raymond Firth

Other Named Officer
BRGX · BIOREGENX, INC.
Effective
2024-03-08
Filed
April 1, 2024, 7:59 PM ET
Effective March 8, 2024, Raymond Firth and Thomas Powers resigned as officers of the Registrant
Appointed (interim)

William Resides

Chief Executive Officer, Interim Financial Officer
BRGX · BIOREGENX, INC.
Effective
2024-03-08
Filed
April 1, 2024, 7:59 PM ET
the following officers were appointed: William Resides – Chief Executive Officer, Interim Financial Officer Robert Doran – Executive Vice President Sherri Adams – Chief Operating Officer Gary Hennerberg – Secretary

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sherri Adams was appointed as director at BIOREGENX, INC..

Action
appointed
Role
director
Exact text from the filing
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides, Robert Doran, Sherri Adams, Gary Hennerberg, Suzanne Bird, Jody Walker, Gary Kiss
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Gary Hennerberg was appointed as Secretary at BIOREGENX, INC..

Action
appointed
Role
Secretary
Exact text from the filing
the following officers were appointed: William Resides – Chief Executive Officer, Interim Financial Officer Robert Doran – Executive Vice President Sherri Adams – Chief Operating Officer Gary Hennerberg – Secretary
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Jody Walker was appointed as director at BIOREGENX, INC..

Action
appointed
Role
director
Exact text from the filing
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides, Robert Doran, Sherri Adams, Gary Hennerberg, Suzanne Bird, Jody Walker, Gary Kiss
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Gary Hennerberg was appointed as director at BIOREGENX, INC..

Action
appointed
Role
director
Exact text from the filing
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides, Robert Doran, Sherri Adams, Gary Hennerberg, Suzanne Bird, Jody Walker, Gary Kiss
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Robert Doran was appointed as director at BIOREGENX, INC..

Action
appointed
Role
director
Exact text from the filing
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides, Robert Doran, Sherri Adams, Gary Hennerberg, Suzanne Bird, Jody Walker, Gary Kiss
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Raymond Firth resigned as director at BIOREGENX, INC..

Action
resigned
Role
director
Exact text from the filing
Effective March 8, 2024, Raymond Firth resigned as a director of the Registrant
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

William Resides was appointed as director at BIOREGENX, INC..

Action
appointed
Role
director
Exact text from the filing
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides, Robert Doran, Sherri Adams, Gary Hennerberg, Suzanne Bird, Jody Walker, Gary Kiss
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Sherri Adams was appointed as Chief Operating Officer at BIOREGENX, INC..

Action
appointed
Role
Chief Operating Officer
Exact text from the filing
the following officers were appointed: William Resides – Chief Executive Officer, Interim Financial Officer Robert Doran – Executive Vice President Sherri Adams – Chief Operating Officer Gary Hennerberg – Secretary
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Robert Doran was appointed as Executive Vice President at BIOREGENX, INC..

Action
appointed
Role
Executive Vice President
Exact text from the filing
the following officers were appointed: William Resides – Chief Executive Officer, Interim Financial Officer Robert Doran – Executive Vice President Sherri Adams – Chief Operating Officer Gary Hennerberg – Secretary
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Suzanne Bird was appointed as director at BIOREGENX, INC..

Action
appointed
Role
director
Exact text from the filing
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides, Robert Doran, Sherri Adams, Gary Hennerberg, Suzanne Bird, Jody Walker, Gary Kiss
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Thomas Powers resigned as other_named_officer at BIOREGENX, INC..

Action
resigned
Exact text from the filing
Effective March 8, 2024, Raymond Firth and Thomas Powers resigned as officers of the Registrant
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Gary Kiss was appointed as director at BIOREGENX, INC..

Action
appointed
Role
director
Exact text from the filing
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides, Robert Doran, Sherri Adams, Gary Hennerberg, Suzanne Bird, Jody Walker, Gary Kiss
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Raymond Firth resigned as other_named_officer at BIOREGENX, INC..

Action
resigned
Exact text from the filing
Effective March 8, 2024, Raymond Firth and Thomas Powers resigned as officers of the Registrant
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

William Resides was appointed as Chief Executive Officer, Interim Financial Officer at BIOREGENX, INC..

Action
appointed
Role
Chief Executive Officer, Interim Financial Officer
Exact text from the filing
the following officers were appointed: William Resides – Chief Executive Officer, Interim Financial Officer Robert Doran – Executive Vice President Sherri Adams – Chief Operating Officer Gary Hennerberg – Secretary
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

BIOREGENX, INC.: Company name changed to BioRegenx, Inc (effective 2024-03-08).

Change
charter amendment
Effective
2024-03-08
Exact text from the filing
Additionally, the name of the Registrant was changed to BioRegenx, Inc.
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

BIOREGENX, INC.: Filed Certificate of Designation to cure 2013 creation of Series A preferred shares (effective 2024-03-14).

Change
charter amendment
Effective
2024-03-14
Exact text from the filing
Effective March 14, 2024, the Registrant filed a Certificate of Designation (and subsequently, a Certificate of Correction) curing the 2013 creation of the Series A preferred shares and ratifying the issuances of 5,000,000 Series A preferred shares in 2013
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

BIOREGENX, INC.: Increased authorized common stock to 1.5 billion shares (effective 2024-03-08).

Change
charter amendment
Effective
2024-03-08
Exact text from the filing
Effective March 8, 2024, the Registrant filed an Amendment to the Articles of Incorporation which increased the authorized common stock to One Billion Five Hundred Thousand (1,500,000,000) common shares.
View on SEC.gov
M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

BIOREGENX, INC. underwent a change of control involving BioRegenx, Inc. (closed 2024-03-08).

Action
change of control
Counterparty
BioRegenx, Inc.
Closing
2024-03-08
Exact text from the filing
The Registrant filed Articles of Merger effective March 8, 2024 with the state of Nevada. Pursuant to the Articles of Merger, BioRegenx, Inc, a Nevada corporation was merged into the Registrant with the Registrant being the surviving company.
View on SEC.gov

55 governance changes filed in the last 30 days. Browse all governance changes →

BIOREGENX, INC. filing history →

Source: SEC EDGAR
accession 0001683168-24-001917
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.